Amneal Pharmaceuticals, Inc.
Ticker: 1723128
values in millions
Revenue & Profit Trend
in millionsRevenueExpenditureNet Profit
Margin Trend
percentageOPM %NPM %
| Period | Q3 FY26 | Q2 FY26 | Q1 FY26 | Q3 FY25 | Q2 FY25 | Q1 FY25 | Q3 FY24 | Q2 FY24 |
|---|---|---|---|---|---|---|---|---|
| INCOME | ||||||||
| Revenue | 862.68+8.3% | 796.20+10.2% | 722.52-7.9% | 784.51+8.3% | 724.51+4.2% | 695.42-1.0% | 702.47+0.1% | 701.78 |
| Total Income | 862.68+8.3% | 796.20+10.2% | 722.52-7.9% | 784.51+8.3% | 724.51+4.2% | 695.42-1.0% | 702.47+0.1% | 701.78 |
| EXPENSES | ||||||||
| Expenditure | 767.27+15.1% | 666.43+14.8% | 580.75-18.7% | 714.17+16.5% | 613.14+3.0% | 595.07-3.0% | 613.66+1.2% | 606.31 |
| Tax | 2.75+99.3% | 1.38-36.7% | 2.18+109.3% | -23.36-245.1% | 16.10+25.1% | 12.87+250.7% | 3.67+1.4% | 3.62 |
| PROFIT | ||||||||
| PBT | 15.06-78.8% | 70.99-11.5% | 80.18+1636.0% | -5.22-110.1% | 51.71+37.9% | 37.49+143.1% | 15.42-24.4% | 20.41 |
| Net Profit | -21.70-137.6% | 57.66-7.4% | 62.26+2527.0% | 2.37-89.4% | 22.42+83.8% | 12.20+7725.0% | -0.16-102.7% | 5.99 |
| KEY METRICS | ||||||||
| OPM % | 11.06%-5.24pp | 16.30%-3.32pp | 19.62%+10.65pp | 8.97%-6.40pp | 15.37%+0.94pp | 14.43%+1.79pp | 12.64%-0.96pp | 13.60% |
| NPM % | -2.52%-9.76pp | 7.24%-1.38pp | 8.62%+8.32pp | 0.30%-2.79pp | 3.09%+1.34pp | 1.75%+1.78pp | -0.02%-0.88pp | 0.85% |
| EPS | -0.06-133.3% | 0.18-10.0% | 0.20+1900.0% | 0.01-85.7% | 0.07+75.0% | 0.04 | 0.00-100.0% | 0.02 |
Corporate Events
Board MeetingAMRX
202631Jul
Board Meeting
Shareholders approved the acquisition of Kashiv BioSciences,…
SEC Filing ↗ Board MeetingAMRX
20266May
Board Meeting
2026 Annual Meeting of Stockholders to elect directors, appr…
SEC Filing ↗